1. Home
  2. KZIA vs LGCB Comparison

KZIA vs LGCB Comparison

Compare KZIA & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • LGCB
  • Stock Information
  • Founded
  • KZIA 1994
  • LGCB 2011
  • Country
  • KZIA Australia
  • LGCB Japan
  • Employees
  • KZIA N/A
  • LGCB N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • LGCB
  • Sector
  • KZIA Health Care
  • LGCB
  • Exchange
  • KZIA Nasdaq
  • LGCB Nasdaq
  • Market Cap
  • KZIA 6.0M
  • LGCB 7.8M
  • IPO Year
  • KZIA 1999
  • LGCB 2023
  • Fundamental
  • Price
  • KZIA $0.89
  • LGCB $0.26
  • Analyst Decision
  • KZIA Strong Buy
  • LGCB
  • Analyst Count
  • KZIA 2
  • LGCB 0
  • Target Price
  • KZIA $11.50
  • LGCB N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • LGCB 233.3K
  • Earning Date
  • KZIA 03-26-2025
  • LGCB 03-11-2025
  • Dividend Yield
  • KZIA N/A
  • LGCB N/A
  • EPS Growth
  • KZIA N/A
  • LGCB N/A
  • EPS
  • KZIA N/A
  • LGCB N/A
  • Revenue
  • KZIA $1,655,324.00
  • LGCB $10,289,681.00
  • Revenue This Year
  • KZIA $806.89
  • LGCB N/A
  • Revenue Next Year
  • KZIA N/A
  • LGCB N/A
  • P/E Ratio
  • KZIA N/A
  • LGCB N/A
  • Revenue Growth
  • KZIA 248000.00
  • LGCB N/A
  • 52 Week Low
  • KZIA $0.89
  • LGCB $0.17
  • 52 Week High
  • KZIA $15.80
  • LGCB $5.71
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 28.96
  • LGCB 42.97
  • Support Level
  • KZIA $0.90
  • LGCB $0.24
  • Resistance Level
  • KZIA $1.60
  • LGCB $0.28
  • Average True Range (ATR)
  • KZIA 0.24
  • LGCB 0.03
  • MACD
  • KZIA 0.01
  • LGCB 0.00
  • Stochastic Oscillator
  • KZIA 0.00
  • LGCB 46.15

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Copany operates in Japan, Hong Kong and China, with maximum revenue from Japan.

Share on Social Networks: